Tailored Intervention Protocol for Oral Chemotherapy Adherence

Completed · Not applicable

Conditions studied: Cancer

In brief

The primary aim of study is to: 1. Test the effectiveness of a tailored protocol in promoting adherence to oral chemotherapeutic agents in adults receiving a new oral chemotherapeutic agent for breast, colorectal, GIST, renal cell,and hepatocellular cancers. Exploratory Aims: 2. Examine adherence to oral chemotherapeutic agents over time at 2, 4 and 6 months in a sample of breast, colorectal, GIST, renal cell,and HPCC cancers patients. 3. Examine the effects of age, gender, caregiver availability, personal involvement in health care, and depression on adherence to oral chemotherapeutic agents.

Key facts

Study ID

NCT00932490

Run by

Duke University

People needed

48

Starts

2009-08-01

Expected to finish

2012-02-01

Last updated by the study team

2014-07-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• a diagnosis of Breast, Colorectal, GIST, Renal, HPCC, Myeloma and Chronic Leukemia
• 18 years or older
• a treatment regimen that includes at least one oral chemotherapeutic agent
• ability to read and write English
• ability to give informed consent
• ability to have prescriptions for oral chemotherapy filled at the Duke University Medical Center pharmacy

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.